GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Inventories, Inventories Adjustments

Samsung BioLogics Co (XKRX:207940) Inventories, Inventories Adjustments : ₩-77,082 Mil (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Inventories, Inventories Adjustments?

Samsung BioLogics Co's Inventories, Inventories Adjustments for the quarter that ended in Mar. 2025 was ₩-77,082 Mil.

Samsung BioLogics Co's quarterly Inventories, Inventories Adjustments declined from Sep. 2024 (₩-60,330 Mil) to Dec. 2024 (₩-61,826 Mil) and declined from Dec. 2024 (₩-61,826 Mil) to Mar. 2025 (₩-77,082 Mil).

Samsung BioLogics Co's annual Inventories, Inventories Adjustments increased from Dec. 2022 (₩-29,788 Mil) to Dec. 2023 (₩-26,262 Mil) but then declined from Dec. 2023 (₩-26,262 Mil) to Dec. 2024 (₩-61,826 Mil).

Samsung BioLogics Co Inventories, Inventories Adjustments Historical Data

The historical data trend for Samsung BioLogics Co's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Inventories, Inventories Adjustments Chart

Samsung BioLogics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Inventories Adjustments
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,964.35 -7,310.83 -29,788.27 -26,262.25 -61,825.50

Samsung BioLogics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Inventories, Inventories Adjustments Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49,954.36 -35,928.82 -60,329.73 -61,825.50 -77,081.62

Samsung BioLogics Co Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.

Samsung BioLogics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Inventories, Inventories Adjustments
Comparable Companies
XKRX:068270 XKRX:196170 XKRX:326030 XKRX:028300 XKRX:214450 XKRX:087010 XKRX:141080 XKRX:145020 XKRX:302440 XKRX:950160 VRTX ASX:CSL REGN ALNY XBRU:UCB XBRU:ARGX ONC BNTX INSM HKSE:01801
Traded in Other Exchanges
N/A
Address
125, Cheomdan-daero, Yeonsu-gu, Incheon, KOR
Website
https://www.samsungbiologics.com
Founded in 2011, Samsung Biologics is a South Korean contract development and manufacturing organization with a global client base. Europe and the US contribute 90% of its total revenue. It provides end-to-end development and manufacturing services from cell line developments to final commercial manufacturing. As of 2023, Samsung Biologics had a total production capacity of 604,000 liters, one of the largest in the world. Its CDMO services account for 72.4% of its total revenue. The balance comes from subsidiary Samsung Bioepis, acquired in 2022. Samsung Bioepis is involved in developing and manufacturing biosimilars.

Samsung BioLogics Co Headlines

No Headlines